Show
Sort by
-
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma
-
- Journal Article
- A1
- open access
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients
-
Uncovering the immune-modulating role of anti-RANKL therapy for cervical cancer : preliminary results
-
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
-
CD70 and PD-L1 in anaplastic thyroid cancer : promising targets for immunotherapy